Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

The research found specific genes that are more active in balding cells, which could be causing hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

People with Hidradenitis Suppurativa have less diverse skin bacteria and different bacterial metabolism than healthy individuals.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Root hairs are key for developing cereals that can fertilize themselves with nitrogen.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.